000 | 01715 a2200481 4500 | ||
---|---|---|---|
005 | 20250513192146.0 | ||
264 | 0 | _c20001019 | |
008 | 200010s 0 0 eng d | ||
022 | _a0896-8411 | ||
024 | 7 |
_a10.1006/jaut.1999.0319 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMatteson, D M | |
245 | 0 | 0 |
_aInhibition of experimental melanin protein-induced uveitis (EMIU) by targeting nitric oxide via phosphatidylcholine-specific phospholipase C. _h[electronic resource] |
260 |
_bJournal of autoimmunity _cSep 1999 |
||
300 |
_a197-204 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aAutoimmune Diseases _xchemically induced |
650 | 0 | 4 |
_aBridged-Ring Compounds _xtherapeutic use |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 |
_aEnzyme Induction _xdrug effects |
650 | 0 | 4 |
_aEye Proteins _ximmunology |
650 | 0 | 4 | _aFas Ligand Protein |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aMelanins _ximmunology |
650 | 0 | 4 |
_aMembrane Glycoproteins _xisolation & purification |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aNorbornanes |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 | _aThiocarbamates |
650 | 0 | 4 |
_aThiones _xtherapeutic use |
650 | 0 | 4 |
_aType C Phospholipases _xantagonists & inhibitors |
650 | 0 | 4 |
_aUvea _xpathology |
650 | 0 | 4 |
_aUveitis _xchemically induced |
700 | 1 | _aShen, D F | |
700 | 1 | _aChan, C C | |
773 | 0 |
_tJournal of autoimmunity _gvol. 13 _gno. 2 _gp. 197-204 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1006/jaut.1999.0319 _zAvailable from publisher's website |
999 |
_c10436793 _d10436793 |